TBG Diagnostics Limited (ASX:TDL) announced that its 100% owned subsidiary TBG Biotechnology Corp received an Emergency Use Authorisation from the US Food and Drug Administration for its ExProbeTM SARS-CoV-2 Testing Kit.
ExProbeTM is an RNA based diagnostic kit that uses real time PCR technology with multiplex model to detect distinctive segments within RdRP, N and E genes of the SARS-CoV-2 virus in a single reaction.
The US Food and Drug Administration has made this kit available under an emergency access mechanism known as EUA for the detection and/or diagnosis of COVID-19.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.